A clinical case of chronic refractory immune thrombocytopenia in a teenager with comorbid antiphospholipid syndrome, modern treatment approaches

Relevance. Chronic refractory immune thrombocytopenia (ITP), especially associated with other autoimmune disorders, is a challenging clinical problem that requires an individualized therapeutic approach. Objective. To present and analyze a clinical case of chronic refractory ITP in an adolescent with comorbid antiphospholipid syndrome (APS) and to discuss modern treatment strategies for such patients. Materials and methods. A clinical observation of patient Kh., 14 years old, from November 2023 to September 2025 is described. Data from clinical examination, laboratory (complete blood count, immunological tests) and instrumental (bone marrow aspiration) methods, as well as specialist consultations were used. Results. A patient with typical ITP onset after ARVI developed a chronic, glucocorticoid-dependent and refractory course. Associated immune disorders (positive direct Coombs test, lupus anticoagulant, ANA) were identified, leading to the verification of APS. Prednisolone therapy induced remission but caused Cushing's syndrome. Monotherapy with romiplostim lost efficacy after 4 months. Stable remission (platelets 159×109/L) was achieved only with combined therapy of rituximab, mycophenolate mofetil and romiplostim. Conclusions. Management of refractory ITP associated with an overlapping autoimmune syndrome requires thorough immunological investigation and readiness to use combined immunosuppressive regimens. The presented case demonstrates the efficacy of the rituximab and mycophenolate mofetil combination in the setting of standard therapy failure. Keywords: immune thrombocytopenia, antiphospholipid syndrome, rituximab, mycophenolate mofetil, refractory disease, adolescent. For citation: Bazina I.B., Davydova Y.V., Molotkova S.A., Stepchenko S.S.

Authors

Publication Details

Journal
Clinical review for general practice
Published
2026-11-16
DOI
https://doi.org/10.47407/kr2026.7.09.00p4561
Primary Topic
Platelet Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

A clinical case of chronic refractory immune thrombocytopenia in a teenager with comorbid antiphospholipid syndrome, modern treatment approaches

Молоткова Светлана Андреевна, I. Bazina, Yaroslava V Davydova, Sofya S Stepchenko
1 links
Clinical review for general practice
Platelet Disorders and Treatments
article

A clinical case of chronic refractory immune thrombocytopenia in a teenager with comorbid antiphospholipid syndrome, modern treatment approaches

Молоткова Светлана Андреевна, I. Bazina, Yaroslava V Davydova, Sofya S Stepchenko
article en

Abstract

Relevance. Chronic refractory immune thrombocytopenia (ITP), especially associated with other autoimmune disorders, is a challenging clinical problem that requires an individualized therapeutic approach. Objective. To present and analyze a clinical case of chronic refractory ITP in an adolescent with comorbid antiphospholipid syndrome (APS) and to discuss modern treatment strategies for such patients. Materials and methods. A clinical observation of patient Kh., 14 years old, from November 2023 to September 2025 is described. Data from clinical examination, laboratory (complete blood count, immunological tests) and instrumental (bone marrow aspiration) methods, as well as specialist consultations were used. Results. A patient with typical ITP onset after ARVI developed a chronic, glucocorticoid-dependent and refractory course. Associated immune disorders (positive direct Coombs test, lupus anticoagulant, ANA) were identified, leading to the verification of APS. Prednisolone therapy induced remission but caused Cushing's syndrome. Monotherapy with romiplostim lost efficacy after 4 months. Stable remission (platelets 159×109/L) was achieved only with combined therapy of rituximab, mycophenolate mofetil and romiplostim. Conclusions. Management of refractory ITP associated with an overlapping autoimmune syndrome requires thorough immunological investigation and readiness to use combined immunosuppressive regimens. The presented case demonstrates the efficacy of the rituximab and mycophenolate mofetil combination in the setting of standard therapy failure. Keywords: immune thrombocytopenia, antiphospholipid syndrome, rituximab, mycophenolate mofetil, refractory disease, adolescent. For citation: Bazina I.B., Davydova Y.V., Molotkova S.A., Stepchenko S.S.

Clinical review for general practiceVol. 7(9)
Good health and well-being
Platelet Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon